Attached files
file | filename |
---|---|
8-K - FORM 8-K - CEB Inc. | c04743e8vk.htm |
EX-99.1 - EX-99.1 - CEB Inc. | c04743exv99w1.htm |
EX-99.2 - EX-99.2 - CEB Inc. | c04743exv99w2.htm |
EX-14.1 - EX-14.1 - CEB Inc. | c04743exv14w1.htm |
Exhibit 99.3
FOR IMMEDIATE RELEASE
Contacts: |
||
Leslie Tullio (Editorial)
|
1919 North Lynn Street | |
+1.571.303.5689
|
Arlington, Virginia 22209 | |
ltullio@executiveboard.com
|
www.executiveboard.com | |
June Connor (Investor) |
||
+1.571.303.6956 |
||
jconnor@executiveboard.com |
CORPORATE EXECUTIVE BOARD & NYSE EURONEXT
ANNOUNCE STRATEGIC PARTNERSHIP
ANNOUNCE STRATEGIC PARTNERSHIP
NYSE-Listed Companies Benefit from Access to Proprietary Insights on Corporate Performance
and Investor Perspectives
and Investor Perspectives
ARLINGTON, Va. Aug. 9, 2010 The Corporate Executive Board (CEB) (NASDAQ: EXBD), a leading
research and advisory services company, today announced it has entered into an alliance with NYSE Euronext
(NYSE: NYX), the worlds leading and most liquid equities exchange group, that will offer
NYSE-listed companies exclusive benefits drawn from CEBs proprietary data and insights. It will
also enable the NYSE to deliver deeper, more actionable business insights around corporate
performance and investor perspectives to its listed companies.
NYSE is pleased to partner with CEB to extend CEBs thought-provoking, performance-focused
programs to our listed companies, said Scott Cutler, EVP and co-Head of U.S. Listing and Cash
Execution, NYSE Euronext. We view CEB as an authoritative provider of the types of data and tools,
best practice research, and peer insights that our listed companies need to assess their relative
valuation, communicate effectively with shareholders, and drive corporate performance.
The CEB/NYSE relationship will focus initially on offerings from CEBs Finance and Strategy Practice.
NYSE-listed CFOs and heads of IR who are interested in CEB membership will be offered
exclusive benefits, including the NYSE Market Valuation Diagnostic. The NYSE Market Valuation
Diagnostic is a sophisticated analytical tool developed to meet the distinct needs of NYSE-listed
companies. The tool combines a listed companys historical performance, current valuation, and
analyst estimates to provide a view of key valuation drivers and strategies for closing valuation
gaps drawn from CEBs deep analysis of corporate best practices.
This alliance will help NYSE-listed companies drive corporate performance by arming them with
actionable data and analysis, said Thomas L Monahan, III, CEB Chairman and CEO. Were honored
that the NYSE sees the value in CEBs unique insights, and were confident that the partnership
will be a great vehicle for introducing the power of CEBs assets to more CFOs and their teams on a
global basis.
Beyond the exclusive membership offerings, NYSE will broaden its popular Digital Exchange webinar
series to include CEBs proprietary content. In addition, NYSEs global CFO and investor relations
roundtables and networking events will include CEB leadership, who will address emerging trends and
issues.
CEB also announced today that it will transfer the listing of its common stock to the NYSE. CEB
expects to begin trading on the NYSE on Aug. 20, 2010 using its current symbol EXBD. The company
will continue to trade on the NASDAQ until the transfer is completed.
We are thrilled to welcome CEB to the NYSE community where it will trade among the worlds most
valuable and powerful brands, Mr. Cutler concluded.
For more information about the CEB/NYSE partnership, please visit www.nyse.com. For more
information about CEB investor relations, please click here.
About the Corporate Executive Board
The Corporate Executive Board drives faster, more effective decision-making among the worlds
leading executives and business professionals. As the premier, network-based knowledge resource, it
provides them with the authoritative and timely guidance needed to excel in their roles, take
decisive action and improve company performance. Powered by an executive network that spans over 50
countries and represents more than 85% of the worlds Fortune 500 companies, the Corporate
Executive Board offers the unique research insights along with an integrated suite of exclusive
tools and resources that enable the worlds most successful organizations to deliver superior
business outcomes. For more information, visit www.exbd.com.
About NYSE Euronext
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative
trading technologies. The companys exchanges in Europe and the United States trade equities,
futures, options, fixed-income and exchange-traded products. With more than 3,700 listed operating
companies, NYSE Euronexts equities markets the New York Stock Exchange, NYSE Euronext, NYSE
Amex, NYSE Alternext and NYSE Arca represent one-third of the worlds equities trading, the most
liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading
European derivatives businesses and the worlds second-largest derivatives business by value of
trading. The company offers comprehensive commercial technology, connectivity and market data
products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the
only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit:
http://www.nyx.com.
###